Trials / Active Not Recruiting
Active Not RecruitingNCT05345509
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.
A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Inventage Lab., Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003
Detailed description
A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aricept Tablet | Donepezil Tablet once daily P.O |
| DRUG | IVL3003 | Donepezil Long-Acting Injection, once S.C Injection |
| DRUG | IVL3003 | Donepezil Long-Acting Injection, once IM Injection |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2025-11-13
- Completion
- 2025-11-13
- First posted
- 2022-04-26
- Last updated
- 2024-12-19
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05345509. Inclusion in this directory is not an endorsement.